FADD was deficient in certain types of cancer, such as thymic lymphoma, acute myeloid leukemia (AML), and glioblastoma (GBM) (Newton et al. 2000; Tourneur et al. 2004; Wang et al. 2017). Here, FADD is linked to glioblastoma.